Citracal® Petites
Natural health product licensed in Canada
- Licence holder
- Bayer Inc.
- NPN or DIN-HM
- 80005450
- Status
- Inactive licence
- Licence date
- 8 April 2008
- Revision date
- 21 July 2010
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Sorbate de potassium, Croscarmellose de sodium, Gélatine, Povidone, Talc, Huile de fève de soja, Poly(éthylène glycol), Dioxyde de titane, Poly(alcool vinylique), Acide benzoïque, Starch, Corn, alpha-tocophérol, Stéarate de magnésium, Saccharose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 2 Tous les jours |
| Enfants | Not specified | minimum: 1 Comprimé ; maximum: 2 Comprimé | 2 Tous les jours |
Uses authorised in Canada
Vitamin and Mineral supplement. A factor in the maintenance of good health. Helps in the maintenance of bones and teeth. Helps in the development and maintenance of bones and teeth. Helps in the absorption and use of calcium and phosphorus. Vitamin D helps in the absorption and use of calcium and phosphorous. Calcium intake, when combined with sufficient Vitamin D, a healthy diet, and regular exercise, may reduce the risk of developing osteoporosis. Adequate calcium as part of a healthy diet, helps prevent osteoporosis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Avoid using 2 hours prior to or until 4 hours after taking other medications. Keep safely out of reach of children. There is enough drug in the package to seriously harm a child.
Source
Official Health Canada record, licence 80005450
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2010. Photograph the packaging to check whether it has changed. Photograph the packaging